Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation

BACKGROUND: Although immune checkpoint inhibitors (ICIs) are one of the most important treatments for advanced-stage non-small-cell lung cancer (NSCLC), NSCLC patients with ALK-rearranged usually don’t obtain a clinical benefit. The reason may be related to the unique tumor microenvironment (TME). W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Zeng, Jingtong, Zhang, Hao, Zhu, Shuai, Wang, Hanqing, He, Jinling, Yang, Lingqi, Zhou, Ning, Zu, Lingling, Xu, Xiaohong, Song, Zuoqing, Xu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494286/
https://www.ncbi.nlm.nih.gov/pubmed/36159860
http://dx.doi.org/10.3389/fimmu.2022.974581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494286/
https://www.ncbi.nlm.nih.gov/pubmed/36159860
http://dx.doi.org/10.3389/fimmu.2022.974581

Ejemplares similares